Diagnosis and Management of Sleep Disorders in Posttraumatic Stress Disorder: A Review of the Literature

Diagnosis and Management of Sleep Disorders in Posttraumatic Stress Disorder: A Review of the Literature

Shahla Mohsenin, MD, and Vahid Mohsenin, MD

International and societal conflicts and natural disasters can leave physical and mental scars in people who are directly affected by these traumatic experiences. Violent crimes, including rape and physical assaults, combat exposure, and natural disasters constitute examples of traumatic events.1 Posttraumatic stress disorder (PTSD) is the clinical manifestation of these experiences due to the difficulty in justifying these events or ameliorating the mental agony resulting from these traumatic exposures. Following exposure to a traumatic event, individuals who develop PTSD experience different clusters of symptoms, which include re-experiencing the trauma, avoidance of trauma-related stimuli, and persistent symptoms of hyperarousal.1 Nightmares and insomnia are diagnostic symptoms of PTSD1; however, other sleep disturbances such as sleep avoidance, sleep terrors, nocturnal anxiety attacks, acting out dreams, sleep apnea, and periodic leg movement disorder are also frequently reported and observed in PTSD patients.2-4

There is growing evidence that sleep disruption that occurs following trauma exposure may in fact contribute to the pathophysiology of PTSD and poor clinical outcomes.5,6 This review highlights the importance of sleep disorders in patients with PTSD and the challenges that physicians face in their management.

METHOD

English-language, adult research studies published between 1985 and April 2014 were identified via the PubMed database. The search terms used were PTSD AND sleep disorders. We identified 792 original and review articles. Of these, 53 articles discussed or researched sleep disorders in PTSD. Fourteen randomized controlled trials of therapy for PTSD were included in this review.7-20

RESULTS

Epidemiology

Epidemiologic studies indicate that the community prevalence of PTSD ranges from 1% to 10%,21,22 with higher estimates reported in victims of interpersonal violence (20%-30%) and combat veterans (15%-30%). Reports continue to show a 20% prevalence of PTSD in veterans of foreign wars.23 Difficulty initiating or maintaining sleep is reported by 44% of veterans with PTSD, 5.5% of veterans without PTSD, and 5% of civilians without the disorder.24 Another common sleep-related symptom of PTSD is nightmares. Nightmares have been reported by 19% to 71% of patients with PTSD.25 This wide variation in incidence of nightmares has been attributed to differences in the severity of PTSD,26 exposure to combat24 and other forms of aggression,25 and the presence of comorbid psychiatric diagnosis.27

• Sleep disorders in the form of insomnia, nightmares, sleep apnea, and movement disorders during sleep are common in posttraumatic stress disorder (PTSD).
• While antidepressants are effective in the management of global symptoms of PTSD, they have variable and at best a modest effect on sleep disorder complaints.
• Cognitive-behavioral treatment targeted to PTSD and selective α1 antagonists such as prazosin are standard therapeutic options for sleep disorders associated with PTSD.

Normal Sleep

According to the US Department of Health and Human Services,28 adults require 7 to 9 hours of sleep. Sleep comprises 2 main stages: non-rapid eye movement (NREM) and rapid eye movement (REM) sleep. Most dreams occur in REM sleep. In order to prevent acting out the dreams during REM sleep, the central nervous system inhibits voluntary muscles, with the exception of the diaphragm and extraocular muscles. Research shows the importance of sleep in memory consolidation and learning.29

The sleep-wake cycle is regulated by 2 processes: homeostatic and circadian drives. Homeostatic drive increases as a function of the extended wakefulness period, and its effect diminishes during sleep.30 The biochemical basis of this drive is not entirely clear, but it has been shown that sustained neuronal activity can increase adenosine levels in the brain—adenosine levels rise in the basal forebrain during prolonged wakefulness and fall during sleep.31 Circadian drive originates from a rhythmic internal biological clock or circadian pacemaker in the suprachiasmatic nucleus; its rhythmicity is synchronized by entraining the external light-dark cycle. Circadian drive is at its peak around 9 pm. Thus, the balance between the homeostatic and circadian systems results in the strongest sleep drive generally between 2:00 and 4:00 am and a modest sleep drive in the afternoon between 1:00 and 3:00 pm (Figure 1). It has been shown that these drives are also shaped by emotional and cognitive inputs. Cognitive and emotional systems that may be able to override the normal homeostatic and circadian circuitry are doing so by means of inputs to the arousal system.32 Under some conditions, such as in shift work or during an emergency situation, this ability to overcome the more basic drives can be adaptive. However, when emotional states such as stress prevent sleep, the balance between homeostatic and circadian systems is perturbed as in poor sleep hygiene and irregular sleep-wake cycles, leading to insomnia as seen in PTSD.

Sleep in PTSD

Nightmares are highly prevalent and considered hallmarks of PTSD.4 Nightmares are reported in as many as 71% of patients with PTSD.2 Nightmares are primarily a REM sleep phenomenon since dream recalls are more common in REM than in NREM sleep. Nightmares may cause short or prolonged awakenings from sleep. Large studies of patients who had experienced a range of traumas indicate an increase of 60% in prevalence of disturbed sleep compared to those without PTSD.25,33 Insomnia is thought to arise primarily from NREM sleep disruption. Other NREM sleep disturbances often observed in trauma-exposed patients with PTSD include nocturnal panic attacks and sleep terrors.34-36 Presence of both nightmares and insomnia within 1 month posttrauma predicted the development of PTSD 6 months later.37 Further, there is evidence that disturbed sleep prior to a traumatic event poses an increased risk of PTSD.3,38 However, despite a high prevalence of sleep disorder symptoms, objective measures of sleep efficiency and fragmentation have been inconsistent. Some polysomnographic studies in PTSD patients have reported REM sleep anomalies,39,40 whereas others have not.41,42 NREM sleep anomalies such as reduced slow-wave sleep have also been reported in some.41 A meta-analysis of polysomnographic studies conducted on military veterans and civilian adults with PTSD43 found a modest increase in REM density and in percentage of stage 1 sleep and reduced slow wave sleep in PTSD compared to non-PTSD groups. The detailed analysis of electroencephalogram (EEG)-for the detection of the cyclic alternating pattern (CAP) and microarousals that are closely tied to autonomic and muscle functions-is more common in patients with PTSD compared to those without PTSD.40 The cyclic alternating pattern during sleep study is characterized by sequences of transient electrocortical events that are distinct from background EEG activity and recur at up to 1-minute intervals. This periodic activity is proposed as a measure of sleep instability and fragmentation and is a stronger predictor of subjective reports of insomnia than conventional definitions of arousals.44,45 So, increased quantities of the cyclic alternating pattern and microarousals could result in nonrestorative sleep and serve to reinforce the perception of constant sleeplessness in these patients.

The exact neurologic mechanisms of sleep disturbances in PTSD are not established. There is accumulating evidence that PTSD is associated with altered brain responses in limbic and paralimbic brain areas—namely, the amygdala and insula—in response to emotional (and typically trauma-related) stimuli.46,47 Recently, resting-state functional magnetic resonance imaging techniques have been applied to investigate the brain basal functional activity and connectivity between brain regions in PTSD.47,48 Specifically, there is some emerging evidence that altered resting-state connectivity between the posterior cingulate cortex and the amygdala may be a reliable prognostic indicator of PTSD symptomatology.49,50 Furthermore, studies have shown altered metabolic activity in frontal, parietal, temporal cortex, and limbic regions in patients with PTSD in comparison with those of controls.51 Thus, clinical observations focusing on the nature of sleep complaints in PTSD, polysomnographic studies, and functional neuroimaging point to a dysregulation in both REM and NREM sleep.

In addition to insomnia and nightmares,52 patients with PTSD have a higher prevalence of sleep apnea and periodic leg movement disorder of sleep.53 Of 110 active duty military personnel with recent combat exposures with a mean age of 33.6 years and a mean body mass index of 30.0 kg/m2, 63% met diagnostic criteria for sleep apnea and 64% for insomnia.4 Those diagnosed with insomnia had the highest rates of PTSD, depression, and mild traumatic brain injury and were more likely to have pain syndrome.4 Sleep disorders are increasingly recognized by medical providers; nonetheless, it is common to ascribe sleep disturbances solely to insomnia or an associated diagnosis, delaying or forgoing a definitive sleep evaluation.

A growing body of research suggests that periodic leg movements are more common in patients with PTSD than in controls. In a study of 25 Vietnam veterans with severe PTSD, 76% of patients had clinically significant periodic leg movement disorder, with a mean index (movements/h) of 38 (normal being < 15/h).54 In another study, periodic leg movements were experienced in 33% of veterans with PTSD and not at all in controls.55 The mechanism for the association between PTSD and periodic leg movements is not clear. It is possible that periodic leg movements are the result of the same neural mechanisms underlying exaggerated daytime startle responses in patients with PTSD, or, alternatively, periodic leg movement disorder may be a risk factor for PTSD.56 Periodic leg movements can be associated with restless legs syndrome and sleep disruption, resulting in complaints of insomnia or excessive daytime sleepiness.

Diagnostic Approach to Patients With PTSD

Individuals with history of physical or mental exposure to traumatic events and symptomatology consistent with PTSD based on DSM-5 criteria should be queried for sleep disorders. The initial screening for sleep disorder may include 2 questions: “How is your sleep?” and “How do you feel when you should be awake?” If either question suggest difficulty falling asleep or staying asleep, waking up unrested, or having excessive daytime sleepiness, more detailed questionnaires containing a sleep-wake diary, Epworth Sleepiness Scale,57 STOP-Bang Questionnaire58 for Sleep-Disordered Breathing, and questions pertaining to restless legs syndrome and periodic leg movements59 are available to further define the nature of the sleep problems. In view of the high prevalence of multiple sleep disorders associated with PTSD, including sleep-disordered breathing and periodic leg movement disorders, a consultation with a sleep medicine specialist might be in order for treatment planning and management. Patients with PTSD who report excessive daytime sleepiness, habitual snoring, witnessed apneas, restless legs, and hypertension on the questionnaires should be considered for sleep study. However, if symptomatology primarily suggests sleep-disordered breathing, home-based respiratory monitoring may suffice.60 Most home-based studies use type III monitors for assessment of respiration and oxygen saturation but not sleep architecture (EEG) or movement disorders (electromyography); therefore, sleep fragmentation and leg movements cannot be assessed. Actigraphy might be a useful tool for assessment of sleep-wake rhythm in subjects with inconsistent sleep pattern and poor sleep hygiene.

Management of Sleep Disorders in PTSD

Nonpharmacologic treatment. The overall management of PTSD is beyond the scope of this review. Readers are referred to Bernardy and Friedman61 for more information. The primary management strategies for insomnia incorporate sleep restriction (which involves curtailing the amount of time spent in bed to approximate the subjective amount of asleep) and stimulus control.62

Cognitive-behavioral treatment for insomnia has been shown to improve sleep disturbances and is considered the first-line therapy.7,8,63,64 In a randomized, 3-arm placebo-controlled trial of sleep behavioral intervention versus prazosin (a centrally acting selective α1 antagonist) and placebo in 57 US military veterans, sleep behavioral intervention and prazosin were more effective than placebo for self-reported and clinician-rated global clinical improvements, reductions in prospective self-reported and diary-based measures of sleep continuity, and nightmare frequency.9 Sleep improvements were found in 62% of those who completed the active treatments and 25% of those randomized to placebo. The core sleep behavioral intervention components included education about nightmares and implementation of imagery rehearsal therapy, education about sleep and insomnia, and stimulus control and sleep restriction.65

A web-based application for smart phones was developed by the US Department of Veterans Affairs National Center for PSTD Dissemination and Training Division (http://www.ptsd.va.gov/public/pages/PTSDcoach.asp) based on fundamentals of cognitive-behavioral treatment targeted for better understanding and self-management of PTSD symptoms. The smart phone application provides educational information about PTSD (eg, symptoms, prevalence, risk factors), various treatment options, self-assessment with interpretative feedback about the severity of their symptoms, ability to track their symptoms over time, coping tools to help address acute PTSD symptoms, and links to find community-based support. In a pilot study,66 the majority of 45 veterans who used the program reported improvement in their symptoms of PTSD. Other modalities, such as an exercise program, have shown some promising results, with a significant reduction in PTSD, anxiety, and depression symptoms that lasted during 1-month follow-up.67,68 There is also growing evidence that mind-body practices are a viable intervention to improve the constellation of PTSD symptoms such as intrusive memories, avoidance, and increased emotional arousal.69

Pharmacologic Treatment

Selective serotonin-norepinephrine reuptake inhibitors. Given the high degree of comorbidity between PTSD and major depressive disorder, and the documented efficacy of selective serotonin reuptake inhibitors (SSRIs) for depressed populations (as well as for a number of other discrete anxiety disorders), SSRIs and selective serotonin-norepinephrine reuptake inhibitors (SNRIs) are first-line medications for the treatment of PTSD.70 In a meta-analysis of 7 randomized trials, patients treated with SSRIs were more likely to experience improvement in symptoms (on the Clinician-Administered PTSD Scale or CAPS) and functioning than the group receiving placebo (RR = 1.59, 95% CI, 1.39-1.82).71 There is a great deal of variation in response to pharmacologic treatment, with few robust individual predictors of response available.72 Some ancillary symptoms of PTSD, such as sleep disturbance, can be particularly difficult to treat and are among the symptoms that result in the use of polypharmacy that is so common in the treatment of PTSD. Selected pharmacologic classes of medications for PTSD that are shown to be effective in randomized controlled trials are listed in Table 1.10-16 Specifically, sertraline and paroxetine improved PTSD symptoms on the CAPS and the clinician-administered Clinical Global Impressions-Improvement (CGI) scale compared to placebo in several randomized controlled trials (Table 1). However, sertraline and paroxetine had no significant effect on sleep disturbance symptoms, including insomnia and nightmare. For a more detailed evidence-based review, the reader is referred to Ipser and Stein.73

Dopamine, serotonin, histamine receptor antagonists. In patients with SSRI-resistant PTSD, olanzapine augmentation was associated with a significantly greater reduction in sleep disturbance, as well as other symptoms of PTSD and depression, compared with placebo.15 Mirtazapine, an antidepressant with serotonin and histamine receptor antagonism, has shown some benefits in PTSD as an alternative to SSRIs (sertraline) in an open-label trial, in part, due to its sedating side effect that can be therapeutically useful to some patients.17 Trazodone, a histamine and α1-adrenergic receptor antagonist, appears to be effective for the treatment of insomnia and nightmares associated with chronic PTSD, but it is not recommended as a first-line therapy for PTSD.61

Selective α1-adrenergic antagonists. Most of the drug trials focused on global PTSD symptoms, with few reporting sleep disturbances as outcome measures. Clinical studies suggest that enhanced postsynaptic adrenergic receptor responsiveness to central nervous system norepinephrine contributes to the pathophysiology of PTSD.74,75 Preclinical studies provide rationale for specific involvement of the postsynaptic α1 adrenoreceptor in this pathophysiologic process. Specifically, central nervous system α1-adrenergic receptor stimulation disrupts sleep physiology and enhances sleep-stage phenomena associated with emergence of trauma nightmares.76 On the basis of the putative noradrenergic alterations seen in PTSD, several pharmacologic agents have been proposed as possible treatments. Prazosin has been more effective than other agents, providing the basis for the findings that α1 receptor stimulation is linked to sleep disruption, stress-induced disruptions in prefrontal cortex cognitive processing, and increased release of corticotropin-releasing hormone,75,77 all phenomena commonly seen in PTSD.46,78 The principal findings of note from these trials were decreased sleep disruption and nightmares and increase in total sleep time and REM sleep.16,18,19 In addition, the improvements in sleep with prazosin were accompanied by significant improvements in daytime symptoms of PTSD. The US Department of Veterans Affairs/Department of Defense practice guidelines recommend prazosin for sleep disturbances and nightmares in PTSD but not for global PTSD.61

Hypnotics. There is insufficient evidence for beneficial effect of hypnotics in PTSD.73 In a small randomized double-blind placebo-controlled crossover trial of escopiclone for 3 weeks in 24 patients with PTSD and associated sleep disturbance, escopiclone improved PTSD symptoms as well as sleep latency and subjective sleep quality.20 However, the current guidelines by the US Department of Veterans Affairs/Department of Defense caution health care providers against the prescription of benzodiazepines in the management of PTSD.61 Additionally, there is evidence that benzodiazepines may interfere with psychotherapy treatments that are first-line intervention in PTSD.79

Treatment of Sleep Apnea

There are several treatment options available for sleep-disordered breathing. These options include positive airway pressure treatment, oral appliance therapy, and upper airway surgery. Positive airway pressure treatment using a nasal or full face mask is the most commonly used therapy. However, it is best for the patient to be referred to a sleep medicine center for evaluation and management.80

Treatment of Periodic Leg Movement Disorder

Many central nervous system-acting medications, particularly SSRIs, can cause or exacerbate periodic leg movement disorders. Dose modification of SSRIs or consideration for the addition of specific therapeutic agents for periodic leg movement disorder may be necessary.81

SUMMARY

Among victims of violence and combat veterans, PTSD is prevalent and is associated with significant burden of anxiety and depression and poor quality of life. In addition, PTSD is associated with high risk for sleep disturbances in the form of sleep fragmentation, nightmares, sleep apnea, and periodic leg movement disorder. All of these sleep disturbances can exacerbate symptoms of PTSD. A thorough clinical evaluation including sleep quality assessment should be part of the overall management of patients with PTSD.

Drug names: mirtazapine (Remeron and others), olanzapine (Zyprexa and others), paroxetine (Paxil, Pexeva, and others), prazosin (Minipress and others), sertraline (Zoloft and others), trazodone (Oleptro and others), venlafaxine (Effexor and others).

Disclosure of off-label usage: The authors have determined that, to the best of their knowledge, mirtazapine, olanzapine, prazosin, trazodone, venlafaxine, and nefazodone are not approved by the US Food and Drug Administration for the treatment of PTSD.

Author affiliations: Private Practice Psychiatry, New Haven, Connecticut (Dr S. Mohsenin) and Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut (Dr V. Mohsenin).

Author contributions: Both authors have contributed equally to the preparation of this manuscript.

Financial disclosure: Drs Mohsenin and Mohsenin have no personal affiliations or financial relationships with any commercial interest to disclose relative to the article.

Funding/support: None reported.

REFERENCES

1. Svenaeus F. Diagnosing mental disorders and saving the normal. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Publishing: Washington, DC; 2013.

2. Krakow B, Haynes PL, Warner TD, et al. Nightmares, insomnia, and sleep-disordered breathing in fire evacuees seeking treatment for posttraumatic sleep disturbance. J Trauma Stress. 2004;17(3):257-268. PubMed doi:10.1023/B:JOTS.0000029269.29098.67

3. Hoge CW, McGurk D, Thomas JL, et al. Mild traumatic brain injury in US soldiers returning from Iraq. N Engl J Med. 2008;358(5):453-463. PubMed doi:10.1056/NEJMoa072972

4. Mysliwiec V, Gill J, Lee H, et al. Sleep disorders in US military personnel: a high rate of comorbid insomnia and obstructive sleep apnea. Chest. 2013;144(2):549-557. PubMed doi:10.1378/chest.13-0088

5. Koren D, Arnon I, Lavie P, et al. Sleep complaints as early predictors of posttraumatic stress disorder: a 1-year prospective study of injured survivors of motor vehicle accidents. Am J Psychiatry. 2002;159(5):855-857. PubMed doi:10.1176/appi.ajp.159.5.855

6. Mellman TA, Bustamante V, Fins AI, et al. REM sleep and the early development of posttraumatic stress disorder. Am J Psychiatry. 2002;159(10):1696-1701. PubMed doi:10.1176/appi.ajp.159.10.1696

7. Krakow B, Hollifield M, Johnston L, et al. Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial. JAMA. 2001;286(5):537-545. PubMed doi:10.1001/jama.286.5.537

8. Krakow B, Johnston L, Melendrez D, et al. An open-label trial of evidence-based cognitive behavior therapy for nightmares and insomnia in crime victims with PTSD. Am J Psychiatry. 2001;158(12):2043-2047. PubMed doi:10.1176/appi.ajp.158.12.2043

9. Germain A, Richardson R, Moul DE, et al. Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US military veterans. J Psychosom Res. 2012;72(2):89-96. PubMed doi:10.1016/j.jpsychores.2011.11.010

10. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283(14):1837-1844. PubMed doi:10.1001/jama.283.14.1837

11. Davidson JR, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58(5):485-492. PubMed doi:10.1001/archpsyc.58.5.485

12. Stein DJ, Davidson J, Seedat S, et al. Paroxetine in the treatment of posttraumatic stress disorder: pooled analysis of placebo-controlled studies. Expert Opin Pharmacother. 2003;4(10):1829-1838. PubMed doi:10.1517/14656566.4.10.1829

13. Davidson J, Baldwin D, Stein DJ, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006;63(10):1158-1165. PubMed doi:10.1001/archpsyc.63.10.1158

14. McRae AL, Brady KT, Mellman TA, et al. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004;19(3):190-196. PubMed doi:10.1002/da.20008

15. Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002;159(10):1777-1779. PubMed doi:10.1176/appi.ajp.159.10.1777

16. Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with posttraumatic stress disorder. Biol Psychiatry. 2007;61(8):928-934. PubMed doi:10.1016/j.biopsych.2006.06.032

17. Chung MY, Min KH, Jun YJ, et al. Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open-label trial. Hum Psychopharmacol. 2004;19(7):489-494. PubMed doi:10.1002/hup.615

18. Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003;160(2):371-373. PubMed doi:10.1176/appi.ajp.160.2.371

19. Taylor FB, Martin P, Thompson C, et al. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008;63(6):629-632. PubMed doi:10.1016/j.biopsych.2007.07.001

20. Pollack MH, Hoge EA, Worthington JJ, et al. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011;72(7):892-897. PubMed doi:10.4088/JCP.09m05607gry

21. Breslau N, Kessler RC, Chilcoat HD, et al. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry. 1998;55(7):626-632. PubMed doi:10.1001/archpsyc.55.7.626

22. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52(12):1048-1060. PubMed doi:10.1001/archpsyc.1995.03950240066012

23. Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med. 2004;351(1):13-22. PubMed doi:10.1056/NEJMoa040603

24. Neylan TC, Marmar CR, Metzler TJ, et al. Sleep disturbances in the Vietnam generation: findings from a nationally representative sample of male Vietnam veterans. Am J Psychiatry. 1998;155(7):929-933.PubMed

25. Ohayon MM, Shapiro CM. Sleep disturbances and psychiatric disorders associated with posttraumatic stress disorder in the general population. Compr Psychiatry. 2000;41(6):469-478. PubMed doi:10.1053/comp.2000.16568

26. Bustamante V, Mellman TA, David D, et al. Cognitive functioning and the early development of PTSD. J Trauma Stress. 2001;14(4):791-797. PubMed doi:10.1023/A:1013050423901

27. Leskin GA, Woodward SH, Young HE, et al. Effects of comorbid diagnoses on sleep disturbance in PTSD. J Psychiatr Res. 2002;36(6):449-452. PubMed doi:10.1016/S0022-3956(02)00025-0

28. Office of Disease Prevention and Health Promotion. Healthy People 2020 Objective Topic Areas. Washington, DC: US Department of Health and Human Services; 2011.

29. Stickgold R. Neuroscience: a memory boost while you sleep. Nature. 2006;444(7119):559-560. PubMed doi:10.1038/nature05309

30. Fuller PM, Gooley JJ, Saper CB. Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback. J Biol Rhythms. 2006;21(6):482-493. PubMed doi:10.1177/0748730406294627

31. Strecker RE, Morairty S, Thakkar MM, et al. Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav Brain Res. 2000;115(2):183-204. PubMed doi:10.1016/S0166-4328(00)00258-8

32. Saper CB, Cano G, Scammell TE. Homeostatic, circadian, and emotional regulation of sleep. J Comp Neurol. 2005;493(1):92-98. PubMed doi:10.1002/cne.20770

33. Foa EB, Riggs DS, Gershuny BS. Arousal, numbing, and intrusion: symptom structure of PTSD following assault. Am J Psychiatry. 1995;152(1):116-120.PubMed

34. Freed S, Craske MG, Greher MR. Nocturnal panic and trauma. Depress Anxiety. 1999;9(3):141-145. PubMed doi:10.1002/(SICI)1520-6394(1999)9:3<141::AID-DA8>3.0.CO;2-5

35. Germain A, Hall M, Krakow B, et al. A brief sleep scale for posttraumatic stress disorder: Pittsburgh Sleep Quality Index Addendum for PTSD. J Anxiety Disord. 2005;19(2):233-244. PubMed doi:10.1016/j.janxdis.2004.02.001

36. Krakow B, Lowry C, Germain A, et al. A retrospective study on improvements in nightmares and posttraumatic stress disorder following treatment for comorbid sleep-disordered breathing. J Psychosom Res. 2000;49(5):291-298. PubMed doi:10.1016/S0022-3999(00)00147-1

37. Harvey AG, Bryant RA. The relationship between acute stress disorder and posttraumatic stress disorder: a prospective evaluation of motor vehicle accident survivors. J Consult Clin Psychol. 1998;66(3):507-512. PubMed doi:10.1037/0022-006X.66.3.507

38. Bryant RA, Creamer M, O’ Donnell M, et al. Sleep disturbance immediately prior to trauma predicts subsequent psychiatric disorder. Sleep. 2010;33(1):69-74.PubMed

39. Mellman TA, Nolan B, Hebding J, et al. A polysomnographic comparison of veterans with combat-related PTSD, depressed men, and non-ill controls. Sleep. 1997;20(1):46-51.PubMed

40. Engdahl BE, Eberly RE, Hurwitz TD, et al. Sleep in a community sample of elderly war veterans with and without posttraumatic stress disorder. Biol Psychiatry. 2000;47(6):520-525. PubMed doi:10.1016/S0006-3223(99)00201-2

41. Woodward SH, Bliwise DL, Friedman MJ, et al. Subjective versus objective sleep in Vietnam combat veterans hospitalized for PTSD. J Trauma Stress. 1996;9(1):137-143. PubMed doi:10.1002/jts.2490090112

42. Hurwitz TD, Mahowald MW, Kuskowski M, et al. Polysomnographic sleep is not clinically impaired in Vietnam combat veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 1998;44(10):1066-1073. PubMed doi:10.1016/S0006-3223(98)00089-4

43. Kobayashi I, Boarts JM, Delahanty DL. Polysomnographically measured sleep abnormalities in PTSD: a meta-analytic review. Psychophysiology. 2007;44(4):660-669. PubMed doi:10.1111/j.1469-8986.2007.537.x

44. Parrino L, Ferrillo F, Smerieri A, et al. Is insomnia a neurophysiological disorder? the role of sleep EEG microstructure. Brain Res Bull. 2004;63(5):377-383. PubMed doi:10.1016/j.brainresbull.2003.12.010

45. Parrino L, Ferri R, Bruni O, et al. Cyclic alternating pattern (CAP): the marker of sleep instability. Sleep Med Rev. 2012;16(1):27-45. PubMed doi:10.1016/j.smrv.2011.02.003

46. Germain A, Buysse DJ, Nofzinger E. Sleep-specific mechanisms underlying posttraumatic stress disorder: integrative review and neurobiological hypotheses. Sleep Med Rev. 2008;12(3):185-195. PubMed doi:10.1016/j.smrv.2007.09.003

47. Sripada RK, King AP, Garfinkel SN, et al. Altered resting-state amygdala functional connectivity in men with posttraumatic stress disorder. J Psychiatry Neurosci. 2012;37(4):241-249. PubMed doi:10.1503/jpn.110069

48. Rabinak CA, Angstadt M, Welsh RC, et al. Altered amygdala resting-state functional connectivity in posttraumatic stress disorder. Front Psychiatry. 2011;2:62. PubMed doi:10.3389/fpsyt.2011.00062

49. Lanius RA, Bluhm RL, Coupland NJ, et al. Default mode network connectivity as a predictor of posttraumatic stress disorder symptom severity in acutely traumatized subjects. Acta Psychiatr Scand. 2010;121(1):33-40. PubMed doi:10.1111/j.1600-0447.2009.01391.x

50. Zhou Y, Wang Z, Qin LD, et al. Early altered resting-state functional connectivity predicts the severity of posttraumatic stress disorder symptoms in acutely traumatized subjects. PLoS ONE. 2012;7(10):e46833. PubMed doi:10.1371/journal.pone.0046833

51. Shin LM, Lasko NB, Macklin ML, et al. Resting metabolic activity in the cingulate cortex and vulnerability to posttraumatic stress disorder. Arch Gen Psychiatry. 2009;66(10):1099-1107. PubMed doi:10.1001/archgenpsychiatry.2009.138

52. Krakow B, Germain A, Tandberg D, et al. Sleep breathing and sleep movement disorders masquerading as insomnia in sexual assault survivors. Compr Psychiatry. 2000;41(1):49-56. PubMed doi:10.1016/S0010-440X(00)90131-7

53. Krakow B, Melendrez D, Pedersen B, et al. Complex insomnia: insomnia and sleep-disordered breathing in a consecutive series of crime victims with nightmares and PTSD. Biol Psychiatry. 2001;49(11):948-953. PubMed doi:10.1016/S0006-3223(00)01087-8

54. Brown TM, Boudewyns PA. Periodic limb movements of sleep in combat veterans with posttraumatic stress disorder. J Trauma Stress. 1996;9(1):129-136. PubMed doi:10.1002/jts.2490090111

55. Mellman TA, Kulick-Bell R, Ashlock LE, et al. Sleep events among veterans with combat-related posttraumatic stress disorder. Am J Psychiatry. 1995;152(1):110-115.PubMed

56. Ross RJ, Ball WA, Dinges DF, et al. Motor dysfunction during sleep in posttraumatic stress disorder. Sleep. 1994;17(8):723-732.PubMed

57. Johns MW. Sensitivity and specificity of the Multiple Sleep Latency Test (MSLT), the Maintenance of Wakefulness Test and the Epworth Sleepiness Scale: failure of the MSLT as a gold standard. J Sleep Res. 2000;9(1):5-11. PubMed doi:10.1046/j.1365-2869.2000.00177.x

58. Farney RJ, Walker BS, Farney RM, et al. The STOP-Bang equivalent model and prediction of severity of obstructive sleep apnea: relation to polysomnographic measurements of the apnea/hypopnea index. J Clin Sleep Med. 2011;7(5):459-65B.PubMed

59. Hilbert J, Mohsenin V. Can periodic limb movement disorder be diagnosed without polysomnography? a case-control study. Sleep Med. 2003;4(1):35-41. PubMed doi:10.1016/s1389-9457(02)00238-1

60. Mohsenin V. Portable monitoring for obstructive sleep apnea: the horse is out of the barn-avoiding pitfalls. Am J Med. 2013;126(4):e1-e3. PubMed doi:10.1016/j.amjmed.2012.05.016

61. Bernardy NC, Friedman MJ. 2010 VA/DOD Clinical Practice Guideline for Management of Posttraumatic Stress: how busy clinicians can best adopt updated recommendations. J Rehabil Res Dev. 2012;49(5):vii-viii. PubMed doi:10.1682/JRRD.2012.02.0036

62. Morgenthaler TI, Kapen S, Lee-Chiong T, et al; Standards of Practice Committee; American Academy of Sleep Medicine. Practice parameters for the medical therapy of obstructive sleep apnea. Sleep. 2006;29(8):1031-1035.PubMed

63. Nishith P, Duntley SP, Domitrovich PP, et al. Effect of cognitive-behavioral therapy on heart rate variability during REM sleep in female rape victims with PTSD. J Trauma Stress. 2003;16(3):247-250. PubMed doi:10.1023/A:1023791906879

64. Zayfert C, DeViva JC. Residual insomnia following cognitive-behavioral therapy for PTSD. J Trauma Stress. 2004;17(1):69-73. PubMed doi:10.1023/B:JOTS.0000014679.31799.e7

65. Germain A, Shear MK, Hall M, et al. Effects of a brief behavioral treatment for PTSD-related sleep disturbances: a pilot study. Behav Res Ther. 2007;45(3):627-632. PubMed doi:10.1016/j.brat.2006.04.009

66. Kuhn E, Greene C, Hoffman J, et al. Preliminary evaluation of PTSD Coach, a smartphone app for posttraumatic stress symptoms. Mil Med. 2014;179(1):12-18. PubMed doi:10.7205/MILMED-D-13-00271

67. Manger TA, Motta RW. The impact of an exercise program on posttraumatic stress disorder, anxiety, and depression. Int J Emerg Ment Health. 2005;7(1):49-57.PubMed

68. Tsatsoulis A, Fountoulakis S. The protective role of exercise on stress system dysregulation and comorbidities. Ann N Y Acad Sci. 2006;1083(1):196-213. PubMed doi:10.1196/annals.1367.020

69. Kim EJ, Dimsdale JE. The effect of psychosocial stress on sleep: a review of polysomnographic evidence. Behav Sleep Med. 2007;5(4):256-278. PubMed doi:10.1080/15402000701557383

70. Jeffreys M, Capehart B, Friedman MJ. Pharmacotherapy for posttraumatic stress disorder: review with clinical applications. J Rehabil Res Dev. 2012;49(5):703-715. PubMed doi:10.1682/JRRD.2011.09.0183

71. Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for posttraumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2006;(1):CD002795.PubMed

72. Ravindran LN, Stein MB. Pharmacotherapy of PTSD: premises, principles, and priorities. Brain Res. 2009;1293:24-39. PubMed doi:10.1016/j.brainres.2009.03.037

73. Ipser JC, Stein DJ. Evidence-based pharmacotherapy of posttraumatic stress disorder (PTSD). Int J Neuropsychopharmacol. 2012;15(6):825-840. PubMed doi:10.1017/S1461145711001209

74. Charney DS, Deutch AY, Krystal JH, et al. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry. 1993;50(4):295-305. PubMed doi:10.1001/archpsyc.1993.01820160064008

75. Southwick SM, Krystal JH, Morgan CA, et al. Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry. 1993;50(4):266-274. PubMed doi:10.1001/archpsyc.1993.01820160036003

76. Pellejero T, Monti JM, Baglietto J, et al. Effects of methoxamine and alpha-adrenoceptor antagonists, prazosin and yohimbine, on the sleep-wake cycle of the rat. Sleep. 1984;7(4):365-372.PubMed

77. Southwick SM, Vythilingam M, Charney DS. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol. 2005;1(1):255-291. PubMed doi:10.1146/annurev.clinpsy.1.102803.143948

78. Germain A, Nofzinger EA, Kupfer DJ, et al. Neurobiology of non-REM sleep in depression: further evidence for hypofrontality and thalamic dysregulation. Am J Psychiatry. 2004;161(10):1856-1863. PubMed doi:10.1176/appi.ajp.161.10.1856

79. van Minnen A, Arntz A, Keijsers GP. Prolonged exposure in patients with chronic PTSD: predictors of treatment outcome and dropout. Behav Res Ther. 2002;40(4):439-457. PubMed doi:10.1016/S0005-7967(01)00024-9

80. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep. 2005;28(4):499-521.PubMed

81. Aurora RN, Kristo DA, Bista SR, et al; American Academy of Sleep Medicine. The treatment of restless legs syndrome and periodic limb movement disorder in adults: an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep. 2012;35(8):1039-1062.PubMed

82. Dijk DJ, Edgar DM. Circadian and homeostatic control of wakefulness and sleep. In: Turek FW, Zee PC, eds. Regulation of Sleep and Circadian Rhythms. New York, NY: Marcel Dekker; 1999:111-147.